{"id":47472,"date":"2022-08-19T12:01:50","date_gmt":"2022-08-19T10:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/"},"modified":"2022-08-19T12:01:50","modified_gmt":"2022-08-19T10:01:50","slug":"real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/","title":{"rendered":"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5012999\/real-world-evidence-solution-market-research?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cjk4nm&amp;utm_campaign=1740021+-+Real+World+Evidence+Solution+Market+Report+2022-2027%3A+Shift+from+Volume+to+Value+Based+Care+%26+Delays+in+Drug+Development+and+the+Subsequent+Increase+in+Development+Costs+Driving+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Real World Evidence Solution Market Research Report by Component (Data Set and Services), Therapeutic Area, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East &amp; Africa) &#8211; Global Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Real World Evidence Solution Market size was estimated at USD 1,078.18 million in 2021, USD 1,219.94 million in 2022, and is projected to grow at a CAGR 13.62% to reach USD 2,319.93 million by 2027.\n<\/p>\n<p>\n<strong>Market Segmentation &amp; Coverage:<\/strong>\n<\/p>\n<p>\nThis research report categorizes the Real World Evidence Solution to forecast the revenues and analyze the trends in each of the following sub-markets:\n<\/p>\n<ul>\n<li>\nBased on Component, the market was studied across Data Set and Services. The Data Set is further studied across Claims Data, Clinical Settings Data, Patient-Powered Data, and Pharmacy Data.\n<\/li>\n<li>\nBased on Therapeutic Area, the market was studied across Cardiovascular, Immunology, Infectious Diseases, Neurology, and Oncology.\n<\/li>\n<li>\nBased on End-User, the market was studied across Biopharmaceutical Company, Clinical &amp; Life Sciences Organization, and Diagnostics or Medical Device Company.\n<\/li>\n<li>\nBased on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East &amp; Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East &amp; Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.\n<\/li>\n<\/ul>\n<p>\n<strong>Competitive Strategic Window:<\/strong>\n<\/p>\n<p>\nThe Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research &amp; development, and new product introduction strategies to execute further business expansion and growth during a forecast period.\n<\/p>\n<p>\n<strong>FPNV Positioning Matrix:<\/strong>\n<\/p>\n<p>\nThe FPNV Positioning Matrix evaluates and categorizes the vendors in the Real World Evidence Solution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.\n<\/p>\n<p>\n<strong>Market Share Analysis:<\/strong>\n<\/p>\n<p>\nThe Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.\n<\/p>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nDrivers\n<\/p>\n<ul>\n<li>\nShift from volume to value based care\n<\/li>\n<li>\nDelays in drug development and the subsequent increase in development costs\n<\/li>\n<li>\nDrug safety and effectiveness after clinical trials\n<\/li>\n<\/ul>\n<p>\nRestraints\n<\/p>\n<ul>\n<li>\nReluctance to rely on real-world studies\n<\/li>\n<\/ul>\n<p>\nOpportunities\n<\/p>\n<ul>\n<li>\nRising focus on end-to-end RWE services\n<\/li>\n<li>\nEmerging roles of wearable devices and AI in RWE\n<\/li>\n<\/ul>\n<p>\nChallenges\n<\/p>\n<ul>\n<li>\nLack of universally accepted methodological standards and data processing infrastructure\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Preface<\/strong>\n<\/p>\n<p>\n<strong>2. Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>3. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4. Market Overview<\/strong>\n<\/p>\n<p>\n<strong>5. Market Insights<\/strong>\n<\/p>\n<p>\n<strong>6. Real World Evidence Solution Market, by Component<\/strong>\n<\/p>\n<p>\n<strong>7. Real World Evidence Solution Market, by Therapeutic Area<\/strong>\n<\/p>\n<p>\n<strong>8. Real World Evidence Solution Market, by End-User<\/strong>\n<\/p>\n<p>\n<strong>9. Americas Real World Evidence Solution Market<\/strong>\n<\/p>\n<p>\n<strong>10. Asia-Pacific Real World Evidence Solution Market<\/strong>\n<\/p>\n<p>\n<strong>11. Europe, Middle East &amp; Africa Real World Evidence Solution Market<\/strong>\n<\/p>\n<p>\n<strong>12. Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>13. Company Usability Profiles<\/strong>\n<\/p>\n<p>\n<strong>14. Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nCertara, L.P.\n<\/li>\n<li>\nClinigen Group PLC\n<\/li>\n<li>\nCognizant Technology Solutions Corp.\n<\/li>\n<li>\nHealthiVibe, LLC\n<\/li>\n<li>\nIBM Corporation\n<\/li>\n<li>\nICON PLC\n<\/li>\n<li>\nIQVIA\n<\/li>\n<li>\nMercy Technology Services\n<\/li>\n<li>\nOracle Corporation\n<\/li>\n<li>\nPAREXEL International Corporation\n<\/li>\n<li>\nPharmaceutical Product Development, LLC\n<\/li>\n<li>\nSAS Institute, Inc.\n<\/li>\n<li>\nSciformix Corporation\n<\/li>\n<li>\nSyneos Health\n<\/li>\n<li>\nTuracoz\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5012999\/real-world-evidence-solution-market-research?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cjk4nm&amp;utm_campaign=1740021+-+Real+World+Evidence+Solution+Market+Report+2022-2027%3A+Shift+from+Volume+to+Value+Based+Care+%26+Delays+in+Drug+Development+and+the+Subsequent+Increase+in+Development+Costs+Driving+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/iju1kf<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x70;&#x72;&#x65;&#x73;&#115;&#64;re&#x73;&#x65;&#x61;&#114;&#99;&#104;an&#x64;&#x6d;&#x61;&#114;&#107;et&#x73;&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#x72;&#101;s&#x65;&#x61;&#x72;&#99;h&#x61;&#x6e;&#x64;&#109;a&#x72;&#x6b;&#x65;&#116;s&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Real World Evidence Solution Market Research Report by Component (Data Set and Services), Therapeutic Area, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East &amp; Africa) &#8211; Global Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Real World Evidence Solution Market size was estimated at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47472","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Real World Evidence Solution Market Research Report by Component (Data Set and Services), Therapeutic Area, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East &amp; Africa) &#8211; Global Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Real World Evidence Solution Market size was estimated at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-19T10:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-19T10:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/\"},\"wordCount\":729,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005123\\\/en\\\/1548646\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/\",\"name\":\"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005123\\\/en\\\/1548646\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-19T10:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005123\\\/en\\\/1548646\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005123\\\/en\\\/1548646\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/","og_locale":"en_US","og_type":"article","og_title":"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Real World Evidence Solution Market Research Report by Component (Data Set and Services), Therapeutic Area, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East &amp; Africa) &#8211; Global Forecast to 2027 &#8211; Cumulative Impact of COVID-19&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Real World Evidence Solution Market size was estimated at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-19T10:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-08-19T10:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/"},"wordCount":729,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/","url":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/","name":"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg","datePublished":"2022-08-19T10:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220819005123\/en\/1548646\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/real-world-evidence-solution-market-report-2022-2027-shift-from-volume-to-value-based-care-delays-in-drug-development-and-the-subsequent-increase-in-development-costs-driving-growth-researchandma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Real World Evidence Solution Market Report 2022-2027: Shift from Volume to Value Based Care &amp; Delays in Drug Development and the Subsequent Increase in Development Costs Driving Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47472"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47472\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}